JNK Antikörper (AA 228-451)
-
- Target Alle JNK (MAPK8) Antikörper anzeigen
- JNK (MAPK8) (Mitogen-Activated Protein Kinase 8 (MAPK8))
-
Bindungsspezifität
- AA 228-451
-
Reaktivität
- C. elegans
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser JNK Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Spezifität
- Reacts with ~53 kDa (alpha form) and at ~42 kDa (beta form) JNK1 from C
- Kreuzreaktivität (Details)
- elegans protein. Does not appear to detect mammalian JNK protein.
- Aufreinigung
- Antiserum
- Immunogen
- A recombinant C. elegans JNK1 alpha protein (residues 228-451)
- Top Product
- Discover our top product MAPK8 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IP : 1/2 000 - WB : 1/2 000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- , Sodium azide 0.05 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C/-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Target
- JNK (MAPK8) (Mitogen-Activated Protein Kinase 8 (MAPK8))
- Andere Bezeichnung
- JNK1 (MAPK8 Produkte)
- Pathways
- MAPK Signalweg, WNT Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, Signaling of Hepatocyte Growth Factor Receptor, S100 Proteine
-